InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43
United States Fiscal year ends December CIK 0001817713
$18.39 -0.59% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $18.39 −2.90% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue0.0Operating income−4.8Net income−6.8Fiscal year 2021Revenue3.6Operating income−32.9Net income−32.7EPS, diluted−1.39Fiscal year 2022Revenue8.6 +136.8%Operating income−67.1Net income−63.1EPS, diluted−1.52Fiscal year 2023Revenue8.1 −6.1%Operating income−73.0Net income−58.3EPS, diluted−1.32Fiscal year 2024Revenue10.6 +31.0%Operating income−98.8Net income−69.0EPS, diluted−1.28Fiscal year 2025Revenue10.0 −5.6%Operating income−157.7Net income−113.6EPS, diluted−1.83
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 3.6 8.6 8.1 10.6 10.0
Growth +136.8% −6.1% +31.0% −5.6%
Operating income −4.8 −32.9 −67.1 −73.0 −98.8 −157.7
Net income −6.8 −32.7 −63.1 −58.3 −69.0 −113.6
Growth
EPS, diluted n/a −1.39 −1.52 −1.32 −1.28 −1.83

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Fiscal year 2021Operating margin−905.4%Net margin−898.3%Free cash flow margin−507.5%Fiscal year 2022Operating margin−779.0%Net margin−732.2%Free cash flow margin−573.2%Fiscal year 2023Operating margin−902.9%Net margin−721.2%Free cash flow margin−648.6%Fiscal year 2024Operating margin−933.6%Net margin−651.6%Free cash flow margin−417.2%Fiscal year 2025Operating margin−1,576.7%Net margin−1,136.3%Free cash flow margin−832.8%
FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −905.4% −779.0% −902.9% −933.6% −1,576.7%
Net margin n/a −898.3% −732.2% −721.2% −651.6% −1,136.3%
Free cash flow margin n/a −507.5% −573.2% −648.6% −417.2% −832.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−4.4Capital expenditure0.0Free cash flow−4.4Fiscal year 2021Operating cash flow−17.0Capital expenditure−1.5Free cash flow−18.5Fiscal year 2022Operating cash flow−42.9Capital expenditure−6.4Free cash flow−49.4Fiscal year 2023Operating cash flow−50.6Capital expenditure−1.9Free cash flow−52.4Fiscal year 2024Operating cash flow−43.8Capital expenditure−0.4Free cash flow−44.2Fiscal year 2025Operating cash flow−82.2Capital expenditure−1.0Free cash flow−83.3
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.4 −17.0 −42.9 −50.6 −43.8 −82.2
Capital expenditure 0.0 −1.5 −6.4 −1.9 −0.4 −1.0
Free cash flow −4.4 −18.5 −49.4 −52.4 −44.2 −83.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash7.8Shareholders’ equity−14.6Fiscal year 2021Cash35.6Shareholders’ equity366.3Fiscal year 2022Cash51.4Shareholders’ equity320.7Fiscal year 2023Cash19.2Shareholders’ equity344.3Fiscal year 2024Cash430.6Shareholders’ equity1,022.8Fiscal year 2025Cash52.3Shareholders’ equity956.8
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 7.8 35.6 51.4 19.2 430.6 52.3
Shareholders’ equity −14.6 366.3 320.7 344.3 1,022.8 956.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−4.4 −17.0 −42.9 −50.6 −43.8 −82.2
Growth
Investment
0.0 −1.5 −6.4 −1.9 −0.4 −1.0
calc −4.4 −18.5 −49.4 −52.4 −44.2 −83.3
Growth
calc n/a −0.78 −1.19 −1.19 −0.82 −1.34
0.0 −341.0 58.3 −41.2 −258.0 −301.0
Financing
11.5 386.5 0.5 59.5 713.2 4.9

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.